Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Review

    2-Deoxy-D-Glucose: A Ray of Hope in COVID Pandemic

    Priyotosh Banerjee1, Indrani Devi Sarma1, Dasgupta Himadri Sekhar1, Dhriti Kumar Brahma1, Melambha Surong1★★ Corresponding author

    1. 1Department of Pharmacology, NEIGRIHMS, Shillong, Meghalaya, India.

    CORRESPONDENCE

    Melambha Surong

    Dhriti Kumar Bramhma, Department of Pharmacology, NEIGRIHMS, Shillong ‑ 793 018, Meghalaya, India.

    dbdhriti168@gmail.com

    Received: 10-06-2021; Revised: 10-08-2021; Accepted: 16-08-2021.

    Volume 12, Issue 3 · pp. 107–109 · PUBLISHED 25 November 2021 · DOI: 10.4103/jpp.jpp_69_21

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Coronavirus disease-19 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 is a respiratory tract infection that has already made a huge negative impact in global health situation. Transmission mainly occurs through droplets, and the virus is highly contagious. Mainly symptomatic treatments are given at present with some drugs for serious patients with unproven efficacy and safety. In this context, Institute of Nuclear Medicine and Allied Sciences, a research laboratory of Defence Research and Development Organization in collaboration with Dr. Reddy’s Laboratories, Hyderabad, has introduced a new medicine named 2-Deoxy-d-glucose (2-DG) (which has been previously tried in cancer) for the treatment of seriously ill COVID patients with a target to reduce the oxygen demand. Clinical trials showed evidence that 2-DG effectively reduces oxygen requirement in seriously ill patients, and real-time polymerase chain reaction conversion is also faster. Recently, 2-DG is approved for the use in critically ill patients by the Drug Controller General of India in May 2021. The introduction of 2-DG brings a new hope in reducing the mortality in COVID patients.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Banerjee, P., Sarma, I. D., Sekhar, D. H., Brahma, D. K., & Surong, M. (2021). 2-Deoxy-D-Glucose: A Ray of Hope in COVID Pandemic. Journal of Pharmacology and Pharmacotherapeutics, 12(3), 107–109. https://doi.org/10.4103/jpp.jpp_69_21